56%, respectively mainly due to the increase of income coupled with the decrease of financing cost. In addition, during 1Q17, its subsidiary (Rajthanee Rojana Hospital Co., Ltd.) has recognized income

Baht 0.5 million in Q1/2019. The interest expenses in Q1/2020 was Baht 1.8 million, or 38.03% decreased from Baht 3.0 million of Q1/2019. This was due to the decrease in short term loan requirement

Reported 94,224.83 96,391.09 Derivative Assets Increase / (Decrease) 143.51 488.56 Investments in Associates and Joint Ventures Increase / (Decrease) (573.93) (785.71) Total Assets - Restated 93,794.41

following details. Financial performance Statement of income Consolidated financial statements for the year 2018 2017 Change (Audited) (Audited/Restated) Increase (Decrease) THB Million % THB Million % THB

unfavorable condition of the Company’s traditional trade channel as the Company appointed a large-sized distributor for the channel since the first quarter of 2018 but later terminated the contract with the

mainly derived from the following reasons:- 1. Management Service (“MS”) had a decrease of gross profit for (3.17) million baht. Main reason was that, in Q3/2018, the company already had a renew contract

a decrease of 44.1 MB or 3.6% due to being in the effect of COVID-19. However, it considerably decreased compared to Q2–2020, representing a decrease of 542.0 MB or 31.3%. This is because in Q2–2020

23.35 million in line with the decrease in services income from digital content via telecommunication channels Total liabilities Total liabilities were mainly consisted of trade and other payables. As at

, the Company and its subsidiary recorded total sales of Baht 1,361 million, a decrease of 10% YoY, following a drop in export CMG and export branded. However, domestic CMG grew outstandingly from new

months, end of September 30, 2018 Financial Statement Consolidate financial statement % revenue from sales Q3/2018 Q3/2017 increase(decrease) Q3/2018 Q3/2017 Revenues from sales 140.51 218.76 (78.25